Zobrazeno 1 - 10
of 1 536
pro vyhledávání: '"Shared epitope"'
Autor:
Marina I. Arleevskaya, Regina V. Larionova, Elena I. Shagimardanova, Natalia E. Gogoleva, Olga A. Kravtsova, Andrej A. Novikov, Gevorg G. Kazarian, Caroline Carlé, Yves Renaudineau
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundA familial history of rheumatoid arthritis (RA) predisposes an individual to develop RA. This study aimed at investigating factors associated with this conversion from the Tatarstan cohort.MethodsA total of 144 individuals, referred to as p
Externí odkaz:
https://doaj.org/article/fd773793c0b9476b9da7f701026a7132
Autor:
Bianka Marklein, Madeleine Jenning, Zoltán Konthur, Thomas Häupl, Franziska Welzel, Ute Nonhoff, Sylvia Krobitsch, Debbie M. Mulder, Marije I. Koenders, Vijay Joshua, Andrew P. Cope, Mark J. Shlomchik, Hans-Joachim Anders, Gerd R. Burmester, Aase Hensvold, Anca I. Catrina, Johan Rönnelid, Günter Steiner, Karl Skriner
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-16 (2021)
Abstract Background There is a need for biomarker to identify patients “at risk” for rheumatoid arthritis (risk-RA) and to better predict the therapeutic response and in this study we tested the hypothesis that novel native and citrullinated hete
Externí odkaz:
https://doaj.org/article/6e28ab54dbcf4c858aedc3ba90e27fcf
Autor:
Wataru Hirose, Masayoshi Harigai, Koichi Amano, Toshihiko Hidaka, Kenji Itoh, Kazutoshi Aoki, Masahiro Nakashima, Hayato Nagasawa, Yukiko Komano, Toshihiro Nanki, for the TOF-ABT Study Group
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-12 (2021)
Abstract Objectives The aim of this study was to compare the clinical effectiveness of tofacitinib and abatacept and clarify the impact of the HLA-DRB1 shared epitope (SE) on responses to these treatments in patients with rheumatoid arthritis (RA). M
Externí odkaz:
https://doaj.org/article/8072e3ec640d40be86ca5bbb0e68cc83
Autor:
Dylan T. Bergstedt, Wyatt J. Tarter, Ryan A. Peterson, Marie L. Feser, Mark C. Parish, Christopher C. Striebich, M. Kristen Demoruelle, LauraKay Moss, Elizabeth A. Bemis, Jill M. Norris, V. Michael Holers, Jess D. Edison, Geoffrey M. Thiele, Ted R. Mikuls, Kevin D. Deane
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Background/PurposeIn rheumatoid arthritis (RA) autoantibodies including antibodies to citrullinated protein antigens (ACPA) and rheumatoid factor (RF) can be predictive of incident clinical RA. However, there is limited understanding of how antibody
Externí odkaz:
https://doaj.org/article/c55d5c1e5a054515822d35369da9f6ce
Autor:
Joanna Wielińska, Katerina Tarassi, Milena Iwaszko, Katarzyna Kościńska, Barbara Wysoczańska, Evangelia Mole, Vasiliki Kitsiou, Jerzy Świerkot, Katarzyna Kolossa, Diamanto Kouniaki, Theofilos Athanassiades, Alexandra Tsirogianni, Katarzyna Bogunia-Kubik
Publikováno v:
Central European Journal of Immunology, Vol 46, Iss 1, Pp 92-98 (2021)
The present study aimed to analyse and compare the distribution of MICA (rs1051792) and NKG2D/KLRK1 (rs1154831, rs1049174, rs2255336) polymorphisms in 61 Greek and 100 Polish patients with rheumatoid arthritis in relation to the presence of the HLA-D
Externí odkaz:
https://doaj.org/article/7ef571b5e3ce4c03a31e3b9fc497a0e8
Autor:
Takeshi Iwasaki, Shuichiro Nakabo, Chikashi Terao, Kosaku Murakami, Ran Nakashima, Motomu Hashimoto, Yoshitaka Imura, Naoichiro Yukawa, Hajime Yoshifuji, Yasuo Miura, Kimiko Yurugi, Taira Maekawa, Myrthe A. M. van Delft, Leendert A. Trouw, Takao Fujii, Tsuneyo Mimori, Koichiro Ohmura
Publikováno v:
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-9 (2020)
Abstract Background The anti-cyclic citrullinated peptide (CCP) antibody is a diagnostic biomarker of rheumatoid arthritis (RA). However, some non-RA connective tissue disease (CTD) patients also test positive for the anti-CCP antibody and, thus, may
Externí odkaz:
https://doaj.org/article/c195d9a8f7024b4584db27527af4faa3
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 12, Pp 589-594 (2020)
Sang Hee Park,1 Xue Han,2 Francis Lobo,2 Sakina Nanji,1 Dipen Patel1 1Modeling and Meta-Analysis, Pharmerit International, Bethesda, MD, USA; 2WW HEOR Markets-US, Bristol-Myers Squibb Company, Lawrenceville, NJ, USACorrespondence: Xue HanBristol-Myer
Externí odkaz:
https://doaj.org/article/ca90f5045a5f45eead6ec7600633d724
Autor:
Fu, Jiaqi, Nogueira, Sarah V., van Drongelen, Vincent, Coit, Patrick, Ling, Song, Rosloniec, Edward F., Sawalha, Amr H., Holoshitz, Joseph
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 2018 May 01. 115(18), 4755-4760.
Externí odkaz:
https://www.jstor.org/stable/26508752
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.